Pricing Log in Create free account

Aktis Oncology, Inc. (AKTS) vs Inventiva S.A. Sponsored ADR (IVA)

Aktis Oncology, Inc. and Inventiva S.A. Sponsored ADR are both Biotechnology companies. Aktis Oncology, Inc. and Inventiva S.A. Sponsored ADR are of similar size ($867.9M and $826.0M). Inventiva S.A. Sponsored ADR has the higher net margin (−750.3% vs −782.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Inventiva S.A. Sponsored ADR leads on 10 and Aktis Oncology, Inc. on 5.

Valuation

Metric AKTS IVA Biotechnology median
P/E n/m n/m 10.60
P/S 90.34 7.43 9.40
P/B 1.80 2.13 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 36.79 1.54 9.02
Earnings yield (264.93%) (94.51%) (32.88%)
Free cash flow yield (15.97%) (94.32%) (23.13%)

Profitability

Metric AKTS IVA Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (939.13%) 0.00% 0.00%
Net margin (781.95%) (750.28%) 0.00%
Free cash flow margin (1,442.91%) 0.00% 0.00%
Return on equity (34.45%) 0.00% (51.96%)
Return on assets (22.22%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKTS IVA Biotechnology median
Revenue growth (TTM) — 547.89% 6.76%
EPS growth (last fiscal year) (25.43%) 35.44% 29.88%
Revenue growth, 5-year CAGR — 8.33% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AKTS IVA Biotechnology median
Debt to equity 0.00 1.13 0.00
Current ratio 16.33 3.81 4.97
Net debt to EBITDA 2.95 0.29 1.01

Dividend

Metric AKTS IVA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AKTS IVA Biotechnology median
Market cap 825.95m 867.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack